sb 203580 has been researched along with promegestone in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (promegestone) | Trials (promegestone) | Recent Studies (post-2010) (promegestone) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 738 | 36 | 41 |
| Protein | Taxonomy | sb 203580 (IC50) | promegestone (IC50) |
|---|---|---|---|
| Progesterone receptor | Homo sapiens (human) | 0.0002 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 1.3183 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horwitz, KB; Lange, CA; Shen, T | 1 |
1 other study(ies) available for sb 203580 and promegestone
| Article | Year |
|---|---|
Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome.
Topics: Acetylcysteine; Breast Neoplasms; Consensus Sequence; Cysteine Endopeptidases; Down-Regulation; Enzyme Inhibitors; Female; Glycoproteins; HeLa Cells; Humans; Imidazoles; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Multienzyme Complexes; Neoplasm Proteins; Phosphorylation; Phosphoserine; Promegestone; Proteasome Endopeptidase Complex; Protein Isoforms; Protein Processing, Post-Translational; Pyridines; Receptors, Progesterone; Recombinant Fusion Proteins; Ubiquitins | 2000 |